Methodology

All entries for: Sonnet Biotherapeutics Inc.

May 28, 2026

Sonnet Biotherapeutics Inc.

Orphan Drug Designation

treatment of soft tissue sarcoma

Disease Area: Rare Diseases
Source
Scroll to Top